Literature DB >> 3788407

Errors in clinical assessment of glycemic control in patients with non-insulin-dependent diabetes mellitus.

A Ramachandran, L Susheela, V Mohan, M Viswanathan.   

Abstract

Errors in the assessment of glycemic control by clinicians, using the conventional method, based on random blood glucose and clinical parameters other than HbA1, were assessed in 125 non-insulin-dependent diabetic (NIDDM) patients (Group B). The expected mean post-prandial plasma glucose concentrations (y) for these patients were obtained from their HbA1 values (x) using the regression equation y = 39.6 X x - 157.6. This equation was derived using the data from 35 NIDDM patients (Group A), in whom mean post-prandial plasma glucose concentrations (measured twice daily), correlated excellently (r = 0.82; n = 100; p less than 0.001) with mean HbA1 values (measured monthly) determined over a period of 3 months. A comparison of the observed and expected post-prandial plasma glucose concentrations in Group B indicated that only an overall 42% of the total (n = 455) observed values (as against 60% in Group A) fell within the 99% confidence limits of the expected mean value. Fifty-eight % of the observed plasma glucose values fell outside the expected range of which 36% were underestimates and 22% were overestimates. Thus, we concluded that even in patients with stable diabetes the physician's assessment of the overall degree of glycemic control should be based on both plasma glucose and HbA1 concentrations for optimizing therapeutic measures.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3788407     DOI: 10.1007/bf02624708

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  7 in total

1.  Specific determination of blood glucose with o-toluidine.

Authors:  A HYVARINEN; E A NIKKILA
Journal:  Clin Chim Acta       Date:  1962-01       Impact factor: 3.786

2.  The clinical information value of the glycosylated hemoglobin assay.

Authors:  D M Nathan; D E Singer; K Hurxthal; J D Goodson
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

3.  Evaluation of glycosylated hemoglobin diabetic patients.

Authors:  H F Bunn
Journal:  Diabetes       Date:  1981-07       Impact factor: 9.461

Review 4.  The clinical utility of glycosylated hemoglobin.

Authors:  L Jovanovic; C M Peterson
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

5.  Hemoglobin A1c compared with three conventional measures of diabetes control.

Authors:  M H Blanc; D M Barnett; R E Gleason; P J Dunn; J S Soeldner
Journal:  Diabetes Care       Date:  1981 May-Jun       Impact factor: 19.112

6.  Colorimetric measurement of glycosylated protein in whole blood, red blood cells, plasma and dried blood.

Authors:  J Eross; D Kreutzmann; M Jimenez; R Keen; S Rogers; C Cowell; R Vines; M Silink
Journal:  Ann Clin Biochem       Date:  1984-11       Impact factor: 2.057

7.  Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes.

Authors:  P A Svendsen; T Lauritzen; U Søegaard; J Nerup
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.